Eli Lilly As of Q2 2025, Eli Lilly holds approximately 57% of the GLP-1 market, overtaking Novo Nordisk earlier this year
Alcohol increases pancreatitis risk on its own
For Nausea and Vomiting: Antiemetic medications can provide relief
Click on the red text to be redirected to a scientific article
5 New strategies for drug development The emergence of resistance from the prolonged or monotherapeutic use of traditional antifungal agents, combined with the low success rate of new drug development, continues to hinder effective treatment of clinical fungal infections
I review each patients health history, current dose, and side effect pattern before recommending a switch, then monitor closely in the weeks after starting tirzepatide